These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36531956)

  • 21. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma.
    Meijing Z; Tianhang L; Biao Y
    Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival.
    Li H; Wu Z; Zhang Y; Lu X; Miao L
    Front Oncol; 2023; 13():1201297. PubMed ID: 37377916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
    Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
    Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma.
    Chang J; Wu H; Wu J; Liu M; Zhang W; Hu Y; Zhang X; Xu J; Li L; Yu P; Zhu J
    J Transl Med; 2023 Mar; 21(1):191. PubMed ID: 36915111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A ferroptosis-related gene in Helicobacter pylori infection, SOCS1, serves as a potential prognostic biomarker and corresponds with tumor immune infiltration in stomach adenocarcinoma: In silico approach.
    Yan P; Cheng M; Wang L; Zhao W
    Int Immunopharmacol; 2023 Jun; 119():110263. PubMed ID: 37156031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASF1B acted as a prognostic biomarker for stomach adenocarcinoma.
    Zhao C; Zhou J; Xing J; Yin Q
    Medicine (Baltimore); 2023 Dec; 102(48):e35408. PubMed ID: 38050219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer.
    Ni X; Chen C; Cui G; Ding W; Liu J
    Front Immunol; 2022; 13():932876. PubMed ID: 35837397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of a novel molecular classification incorporating oxidative stress and metabolism-related genes for stomach adenocarcinoma in the framework of predictive, preventive, and personalized medicine.
    Dong Y; Yuan Q; Ren J; Li H; Guo H; Guan H; Jiang X; Qi B; Li R
    Front Endocrinol (Lausanne); 2023; 14():1090906. PubMed ID: 36860371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Analysis of the Prognostic Value and Immune Function of Immune Checkpoints in Stomach Adenocarcinoma.
    Shen K; Liu T
    Int J Gen Med; 2021; 14():5807-5824. PubMed ID: 34557032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma.
    Zhang L; Zhang Q; Huang Z; Zhu M; Wang T; Zhu W; Wang X; Zhou X
    Biomed Res Int; 2022; 2022():2053719. PubMed ID: 36193316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Multi-Omics Study on the Effect of Helicobacter Pylori-Related Genes in the Tumor Immunity on Stomach Adenocarcinoma.
    Wu X; Jian A; Tang H; Liu W; Liu F; Liu S; Wu H
    Front Cell Infect Microbiol; 2022; 12():880636. PubMed ID: 35619651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development a m
    Shi G; Li Y; Gao H; Wei Y; Wang Y
    Aging (Albany NY); 2023 Mar; 15(6):1944-1963. PubMed ID: 37019148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Necroptosis-Related Molecular Subtypes and Therapeutic Response in Lung Adenocarcinoma.
    Zhang J; He X; Hu J; Li T
    Front Genet; 2022; 13():920350. PubMed ID: 35754848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a Metabolic Reprogramming-Associated Risk Model Related to Prognosis, Immune Microenvironment, and Immunotherapy of Stomach Adenocarcinoma.
    Zhao Y; Zhang D; Sun Y
    J Oncol; 2022; 2022():7248572. PubMed ID: 36185624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma.
    Zeng C; Liu Y; He R; Lu X; Dai Y; Qi G; Liu J; Deng J; Lu W; Jin J; Liu Q
    Front Genet; 2022; 13():935056. PubMed ID: 36092903
    [No Abstract]   [Full Text] [Related]  

  • 40. A degradome-related signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma based on machine learning procedure.
    Deng Z; Feng Q; Zhao D; Huang Z
    Medicine (Baltimore); 2024 Apr; 103(15):e37728. PubMed ID: 38608069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.